Literature DB >> 10873593

Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia.

R Wieser1, A Volz, U Vinatzer, K Gardiner, U Jäger, M Mitterbauer, A Ziegler, C Fonatsch.   

Abstract

Rearrangements affecting chromosome band 3q21 are observed in a subgroup of patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). However, little is known about the molecular consequences of such aberrations. We therefore established a PAC contig in the 3q21 breakpoint region and identified potential protein coding sequences by exon trapping. One of the exons isolated was from the human GATA-2 gene, which we showed to be transcribed from telomere to centromere. The majority of 3q21 breakpoints are located telomeric to the transcribed portion of this gene in a region that in mice appears to be necessary for proper promoter function. Results of GATA-2 expression analyses in leukemic cell lines as well as primary patient samples are compatible with the hypothesis that 3q21 aberrations contribute to leukemogenesis through deregulation of the hematopoietic transcription factor GATA-2. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873593     DOI: 10.1006/bbrc.2000.2947

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.

Authors:  Christopher Slape; Helge Hartung; Ying-Wei Lin; Juraj Bies; Linda Wolff; Peter D Aplan
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

2.  A patient with a germline GATA2 mutation and primary myelofibrosis.

Authors:  Cyrill V Rütsche; Eugenia Haralambieva; Veronika Lysenko; Stefan Balabanov; Alexandre P A Theocharides
Journal:  Blood Adv       Date:  2021-02-09

3.  Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Christopher N Hahn; Chan-Eng Chong; Catherine L Carmichael; Ella J Wilkins; Peter J Brautigan; Xiao-Chun Li; Milena Babic; Ming Lin; Amandine Carmagnac; Young K Lee; Chung H Kok; Lucia Gagliardi; Kathryn L Friend; Paul G Ekert; Carolyn M Butcher; Anna L Brown; Ian D Lewis; L Bik To; Andrew E Timms; Jan Storek; Sarah Moore; Meryl Altree; Robert Escher; Peter G Bardy; Graeme K Suthers; Richard J D'Andrea; Marshall S Horwitz; Hamish S Scott
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

Review 4.  Haematopoietic and immune defects associated with GATA2 mutation.

Authors:  Matthew Collin; Rachel Dickinson; Venetia Bigley
Journal:  Br J Haematol       Date:  2015-02-23       Impact factor: 6.998

5.  GATA2 deficiency and related myeloid neoplasms.

Authors:  Marcin W Wlodarski; Matthew Collin; Marshall S Horwitz
Journal:  Semin Hematol       Date:  2017-05-10       Impact factor: 3.851

6.  Gynecologic manifestations in Emberger syndrome.

Authors:  Hasan Yüksel; Emre Zafer
Journal:  Turk J Obstet Gynecol       Date:  2021-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.